ALTRAZEAL

ALTRAZEAL TRANSFORMING POWDER DRESSING | TRANSFORMING TECHNOLOGY | TRANSFORMING WOUND CARE | TRANSFORMING LIVES

Altrazeal® is a patented powder dressing specially engineered to cover and protect the wound and to provide an ideal moist wound healing environment that supports cellular function and tissue repair. Its non-resorbable, sterile granules aggregate when hydrated with saline to form a moist, flexible, oxygen permeable film that fits and seals the wound. Powder may be added from time to time and secur

ed with simple secondary dressings for more exudative wounds, without requiring primary dressing changes. As the wound heals, the powder dries and flakes off like a scab. Disclaimer: Please see the Altrazeal Instructions for Use for a complete listing of uses, warnings and precautions.

The Altrazeal team had a fantastic day at the 35th European Wound Management Association - EWMA conference, connecting w...
03/27/2025

The Altrazeal team had a fantastic day at the 35th European Wound Management Association - EWMA conference, connecting with clinicians, partners, and innovators from around the world who are just as passionate about advancing wound care as we are.

A big thank you to everyone who stopped by our booth and visited the poster presented by Christina Megal, DNP, FNP-C, CWON-AP—we look forward to collaborating with you to !

For those who were unable to visit us on Day 1, we invite you to stop by our booth ( #126) on Day 2. See you there!

Meet the A-team at booth  #126 at the 35th European Wound Management Association ( ) conference in Barcelona, Spain, to ...
03/26/2025

Meet the A-team at booth #126 at the 35th European Wound Management Association ( ) conference in Barcelona, Spain, to discover how Altrazeal is transforming wound care!

Christina Megal, DNP, FNP-C, CWON-AP, is presenting a compelling poster featuring a case series of three patients (ages 71–74) with chronic wounds unresponsive to standard of care for 13 to 30 weeks. Following treatment with Altrazeal, all wounds achieved complete healing in an average of just 35.7 days—with only 3.3 applications and no debridement required.

Stop by to learn more about these remarkable outcomes and how Altrazeal is redefining healing.

Meet Michael Hickey and Tweesha Shah from the A-Team at booth  #503 at the 7th Annual   (Operational Medicine) Symposium...
03/17/2025

Meet Michael Hickey and Tweesha Shah from the A-Team at booth #503 at the 7th Annual (Operational Medicine) Symposium and Technology Showcase to learn about how Altrazeal can be used to treat complex, painful, difficult to dress wounds.

Looking forward to seeing you there!

EXCITING NEWS: Breaking Boundaries with Biotech InnovationsOur CEO, Vaidehi Shah, has been featured in Forbes and Fortun...
03/04/2025

EXCITING NEWS: Breaking Boundaries with Biotech Innovations

Our CEO, Vaidehi Shah, has been featured in Forbes and Fortune! ALTRAZEAL® Life Sciences Inc. was selected as one of six companies showcased in the April issue of Forbes & Fortune Dallas.

With a background in private equity and a mission-driven approach to healthcare, Vai is leading the charge in transforming wound care worldwide with the successful launch of our first product. This recognition is a testament to her vision and Altrazeal’s impact on patient outcomes.

Thank you to Forbes and Fortune for highlighting our journey!

DATA RELEASE: COMPLEX FULL THICKNESS TRAUMATIC WOUNDSA study presented by Dr. Jonathan Saxe, Vice Chair of Surgery, Asce...
01/28/2025

DATA RELEASE: COMPLEX FULL THICKNESS TRAUMATIC WOUNDS

A study presented by Dr. Jonathan Saxe, Vice Chair of Surgery, Ascension St. Vincent Medical Center and Medical Director, Altrazeal Life Sciences Inc., at the Medical Technology Enterprise Consortium (MTEC) Annual Membership Meeting evaluated how Altrazeal helped treat 10 patients with complex, full thickness traumatic wounds with elements of exposed bones, tendons and muscles. A marked acceleration in healing with reduced frequency of dressing changes relative to the standard of care was achieved in all 10 cases.

DATA RELEASE | RETROSPECTIVE DESCRIPTIVE ANALYSIS OF ALTRAZEAL IN 70 PATIENTS WITH HARD-TO-HEAL WOUNDSAtypical, hard to ...
01/26/2025

DATA RELEASE | RETROSPECTIVE DESCRIPTIVE ANALYSIS OF ALTRAZEAL IN 70 PATIENTS WITH HARD-TO-HEAL WOUNDS

Atypical, hard to heal wounds comprising about 20% of all chronic wounds, are challenging to diagnose, and fail to heal within 4-8 weeks despite standard of care (SOC) treatment plans. Currently, high quality evidence for optimal treatment of these wounds is sparse, and SOC treatments are often ineffective. Chronic wounds impose a significant clinical, financial, and social burden to the individual, the healthcare system and the society at large.

A case series led by University of Hamburg Medical Center in Germany evaluated Altrazeal’s impact on wound healing for 70 patients with hard-to-heal wounds (average duration 19.1 months) that failed SOC treatment.

- Extended 30-day wear time without primary dressing changes was observed in 66% patients (46 wounds).
- 37 of 70 patients (53%) healed as compared to 8% for SOC, based on the European Wound Registry (EWR) cohort over the 14-week study period.
- Treatment goals for 71% (50 patients) were achieved.

Congratulations to Matthias Augustin, MD, Dr. med. Natalia Kirsten, Sandra Wolf, MSc and Susan Rolniak St. John, MSN, APRN-NP for winning the top scoring evidence-based practice award and thank you for believing in Altrazeal!

Today, we honor Dr. King’s unwavering dedication to creating a fairer, more inclusive, and just society. On this Nationa...
01/20/2025

Today, we honor Dr. King’s unwavering dedication to creating a fairer, more inclusive, and just society. On this National Day of Service, we reflect on life’s purpose and focus on how we can serve others. We deeply appreciate your support in helping us make Altrazeal available to people worldwide, including those in underserved areas.

We actively serve patients, payors, and care providers with a shared mission to . Your support fuels our passion to make a difference, inspiring us every step of the way.

We dream of serving all patients. We dream of transforming lives. We dream of healing the world. With your support, we are turning this dream into reality, and for that, we say THANK YOU.

01/17/2025

ANKLE WOUND | PATIENT WITH PERIPHERAL NEUROPATHY

Rosalyn Barnabee, BSN, WON, shares a deeply personal experience using Altrazeal to heal her husband Brian Barnabee’s ankle wound. Despite being a nurse practitioner himself, Brian had tried numerous treatments with little to no success. Drawing on her extensive professional experience with Altrazeal, Rosalyn decided to use it on Brian’s stubborn wound. Altrazeal treatment led to complete healing in 90 days with only five applications.

Thank you, Rosalyn and Brian, for believing in Altrazeal, and joining our mission to .

Visit our website to learn more: www.altrazeal.com

Meet Susan St. John and Tweesha Shah from the A-Team at booth  #205 at the 38th EAST Annual Scientific Assembly in Tucso...
01/15/2025

Meet Susan St. John and Tweesha Shah from the A-Team at booth #205 at the 38th EAST Annual Scientific Assembly in Tucson, AZ to learn about how Altrazeal can be used to treat complex, painful, difficult to dress wounds.

Looking forward to seeing you there!

01/10/2025

ALTRAZEAL PREVENTS AMPUTATION TO SEND AN EGYPTIAN FISHERMAN BACK TO SEA

Altrazeal was used by Dr. Mounir Mabrouk (Chief of Vascular Surgery at طلاب جامعة الاسكندرية- Alexandria University in Egypt and Fellow from The Mount Sinai Hospital in New York) to treat a 42-year-old patient suffering from a painful, progressive venous ulcer with uncontrolled vasculitis and exposed bone. Despite various wound treatments prior to using Altrazeal, the patient was experiencing no improvements.

Thank you Dr. Mounir Mabrouk for presenting this complex case.

The Altrazeal team is truly blessed with people who are on a mission to !

Disclaimer: Please see the Altrazeal Instructions for Use for a complete listing of uses, warnings and precautions.

01/07/2025

DIFFICULT TO HEAL PILONIDAL CYSTS: CLINICIAN TESTIMONIAL

Ann Marie Nie, PhD, MSN, APRN, FNP-BC, CWOCN, shares her experience with Altrazeal in treating chronic pilonidal cysts. Altrazeal filled and protected cavities in challenging locations, creating an environment conducive to healing, and accelerating wound closure while reducing dressing changes and enhancing patient comfort.

Thank you Ann Marie for believing in Altrazeal and joining our mission to .

01/05/2025

Listen to a testimonial by Jim Porter, a 44-year-old individual with a significant necrotizing fasciitis wound treated with Altrazeal. Upon transitioning to Altrazeal, Jim experienced remarkable improvements: Pain scores reduced from 10/10 to 0/10, eliminated the need for opioid and pain medications, decreased home health visits from 3x to 1x weekly, reduced dressing changes (over 20 compared to an estimate 66 dressings - with standard of care over the same time period), successfully avoided grafting, amputation, and readmission. To learn more about how Altrazeal can effectively treat complex, painful, and challenging-to-dress wounds, visit www.altrazeal.com.

01/01/2025

The A-Team from around the world wishes you a very happy new year!

12/15/2024

Pamella Bedessee, a Crohn’s and colitis patient, shares her incredible journey of healing with Altrazeal. After enduring a painful PG wound for over two years, requiring multiple daily dressing changes, Pamella transitioned to Altrazeal—and her wound healed in just two months. With Altrazeal, she experienced remarkable pain relief, fewer dressing changes, and significant savings in nursing time and costs.

Thank you, Pamella, for trusting Altrazeal to transform your care journey.

To hear from the clinicians who supported Pamella in self-administering Altrazeal treatment, click here: https://bit.ly/PeristomalWound-ClinicianTestomonial

12/10/2024

RETROSPECTIVE CASE SERIES: TREATMENT OF 50 ACUTE AND CHRONIC WOUNDS OF MULTIPLE WOUND ETIOLOGIES

In an institutional review board-approved single-centre retrospective case series, the researchers evaluated 50 acute and chronic wounds treated with Altrazeal. Over the 40-day study period, 72% of patients experienced wound healing (≥10% reduction in wound area per week), and 54% of patients had complete wound closure. After treatment with Altrazeal, nearly all wounds, regardless of etiology, location, or chronicity, demonstrated complete wound healing or a reduction in wound surface area with no adverse effects.

Click on the following link to review the study: https://journals.lww.com/aswcjournal/fulltext/2024/11000/treatment_of_50_acute_and_chronic_wounds_of.19.aspx

To learn more about the application of Altrazeal in chronic and atypical wounds, click here: https://altrazeal.com/evidence/

12/08/2024

ANKLE WOUND | PATIENT WITH PERIPHERAL NEUROPATHY

Rosalyn Barnabee, BSN, WON, shares a deeply personal experience using Altrazeal to heal her husband Brian Barnabee's ankle wound. Despite being a nurse practitioner himself, Brian had tried numerous treatments with little to no success. Drawing on her extensive professional experience with Altrazeal, Rosalyn decided to use it on Brian’s stubborn wound. Altrazeal treatment led to complete healing in 90 days with only five applications.

Thank you, Rosalyn and Brian, for believing in Altrazeal, and joining our mission to .

Visit our website to learn more: www.altrazeal.com



Freedom from Diabetes American Diabetes Association

DATA RELEASE: ALTRAZEAL IN SICKLE CELL ASSOCIATED WOUNDSSickle cell associated wounds are notoriously difficult to heal ...
12/05/2024

DATA RELEASE: ALTRAZEAL IN SICKLE CELL ASSOCIATED WOUNDS

Sickle cell associated wounds are notoriously difficult to heal as the treatment involves various challenges including pain, inflammation, chronicity and vascular insufficiency. At the Symposium on Advanced Wound Care (SAWC) Spring 2023 Meeting, Alisha Oropallo, MD and Amit Rao, MD from Northwell Health presented a case series illustrating the use of Altrazeal in sickle cell ulcers.

The study concluded that the implementation of Altrazeal showed significant improvement in the healing trajectory for both patients within a short period of time. The patients also reported reduced pain post-treatment.

To learn more about Altrazeal, click here: www.altrazeal.com

Sickle Cell Intervention (Raising hopes saving lives) | Sickle Cell Warriors

See less

12/01/2024

COMPLEX ABDOMINAL WOUND WITH 13 FISTULAS

Carolyn Cintron, BSN, RN, CWOCN, and Theresa Pineda, BSN, RN, CWOCN, share their experience with Altrazeal in treating a 40-year-old patient with a complex abdominal wound. The patient was undergoing treatment with negative pressure wound therapy, but developed multiple fistula formations. Upon transition to Altrazeal, his bleeding stopped and wound size decreased with an improved pouching surface, leading to a successful fistula takedown surgery followed by full wound closure.

Thank you, Carolyn and Theresa, for trusting Altrazeal and joining our mission to .

To view the poster, click here: https://bit.ly/ComplexFistulaCare

Visit our website to learn more: www.altrazeal.com

Address

4410 Beltway Drive
Addison, TX
75001

Alerts

Be the first to know and let us send you an email when ALTRAZEAL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ALTRAZEAL:

Videos

Share